VOC Diagnostics has developed a patented diagnostic method focusing on the application to ovarian cancer. The method (OC detect) is based on detecting Volatile Organic Compounds, using odor sensors and has in a published study (1) been showing very high sensitivity (92%) and specificity (93%). The company’s vision is an expansion to other cancer diagnosis as well and to reduce mortality globally, increase quality of life.
Impact: Early intervention and significantly reduced mortality.
CEO: Annika EricsonGUV Contact: Jan Pilebjer